Victory Capital Management’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $188K | Buy |
37,058
+695
| +2% | +$3.52K | ﹤0.01% | 2260 |
|
|
2025
Q1 | $192K | Sell |
36,363
-3,550
| -9% | -$18.8K | ﹤0.01% | 2232 |
|
|
2024
Q4 | $270K | Buy |
39,913
+12,519
| +46% | +$84.6K | ﹤0.01% | 2164 |
|
|
2024
Q3 | $181K | Buy |
27,394
+5,503
| +25% | +$36.3K | ﹤0.01% | 2242 |
|
|
2024
Q2 | $164K | Buy |
21,891
+2,598
| +13% | +$19.5K | ﹤0.01% | 2235 |
|
|
2024
Q1 | $192K | Sell |
19,293
-1,148
| -6% | -$11.4K | ﹤0.01% | 2230 |
|
|
2023
Q4 | $202K | Buy |
20,441
+5,195
| +34% | +$51.2K | ﹤0.01% | 2235 |
|
|
2023
Q3 | $117K | Buy |
15,246
+2,912
| +24% | +$22.3K | ﹤0.01% | 2284 |
|
|
2023
Q2 | $92.1K | Sell |
12,334
-288
| -2% | -$2.15K | ﹤0.01% | 2323 |
|
|
2023
Q1 | $84.2K | Sell |
12,622
-575
| -4% | -$3.84K | ﹤0.01% | 2383 |
|
|
2022
Q4 | $102K | Buy |
13,197
+1,135
| +9% | +$8.75K | ﹤0.01% | 2358 |
|
|
2022
Q3 | $128K | Buy |
+12,062
| New | +$128K | ﹤0.01% | 2438 |
|
|
2021
Q3 | – | Sell |
-6,620
| Closed | -$242K | – | 2837 |
|
|
2021
Q2 | $242K | Buy |
+6,620
| New | +$242K | ﹤0.01% | 2486 |
|